东阿阿胶(000423) - 2014 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders decreased by 5.24% to CNY 301,702,581.65 for the current period[4] - Operating revenue decreased by 20.12% to CNY 877,491,441.24 compared to the same period last year[4] - Basic earnings per share decreased by 5.24% to CNY 0.4613 for the current period[5] - The weighted average return on net assets decreased by 1.43% to 5.92%[5] - The net cash flow from operating activities showed a significant decline of 764.07% to CNY -232,350,231.80[4] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 77,867[7] - The largest shareholder, China Resources Dong'a Ejiao Co., Ltd., holds 23.14% of the shares[7] - There were no share buyback transactions conducted by shareholders during the reporting period[9] Asset and Liability Changes - Total assets increased by 13.94% to CNY 6,813,597,102.70 compared to the end of the previous year[4] - Cash and cash equivalents decreased by 40.44% to ¥1,318,570,152.08 due to dividend payments and raw material purchases[12] - Accounts receivable increased by 29.44% to ¥232,909,043.73, primarily due to credit extended to sales customers[12] - Inventory rose by 91.37% to ¥1,054,464,607.26, driven by increased production and procurement of traditional Chinese medicine materials[12] - Other receivables increased by 98.64% to ¥135,494,846.06, largely due to higher inter-company payments[12] - Prepayments grew by 107.45% to ¥426,686,144.92, reflecting increased advance payments for procurement[12] - Accounts payable rose by 157.76% to ¥228,443,668.54, primarily due to increased raw material procurement[12] Investment and Income - Non-recurring gains and losses amounted to CNY 80,440,241.30 for the current period[6] - Investment income surged by 203.45% to ¥82,558,744.99, mainly from increased returns on financial products[12] - The company reported a significant increase in cash received from investment income, up 212.86% to ¥83,638,464.18[13] - The company did not engage in any securities or derivative investments during the reporting period[15][16] Operating Expenses - Operating expenses decreased by 70.25% to ¥791,998.50, mainly due to reduced donation expenditures[12]